Skip to main content
Equibles

Charles S. McKhann

Board Member

Exagen Inc. (XGN)

Equibles does not estimate personal net worth.

Get an email with a short summary when Exagen Inc. publishes a filing, an earnings call transcript or a press release.

Get XGN alerts

About Charles S. McKhann

Charles S. McKhann is recorded as Board Member at Exagen Inc. (XGN). The newest filing on record that lists Charles S. McKhann as Board Member at Exagen Inc. (XGN) is dated April 27, 2026. Exagen Inc. reported in an 8-K filed July 17, 2025 that Charles S. McKhann was appointed Class III director, effective July 17, 2025. Exagen Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Exagen Inc. includes John Aballi (CEO, CFO and Board Member), Tina S. Nova (Chairman), Jeffrey Black (CFO) and 6 others.

“On July 17, 2025, upon the recommendation of the Nominating and Corporate Governance Committee (“Nominating Committee”) of the Board of Directors (the “Board”) of Exagen Inc. (the “Company”), and pursuant to the bylaws of the Company, the Board appointed, effective as of July 17, 2025 (the “Effective Date”), Charles S. McKhann to serve as a Class III director, with an initial term expiring at the Company’s 2028 annual meeting of stockholders.”
Exagen Inc. Form 8-K, filed July 17, 2025 · Read the filing

Affiliation history

  • Exagen Inc. (XGN)

    Board Member

    Proxy statement

    Current

    Start not stated–present

    Last confirmed April 27, 2026

Company network

Exagen Inc.

XGN

Current role

Diagnostics & Research · Healthcare

Board Member

Leadership on record at Exagen Inc.

Recent activity